Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $430,297 - $477,777
-6,754 Reduced 2.27%
290,285 $18.6 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $21,290 - $24,147
324 Added 0.11%
297,039 $20.6 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $86,147 - $102,011
-1,258 Reduced 0.42%
296,715 $21.3 Million
Q3 2022

Nov 09, 2022

BUY
$0.13 - $76.84 $107 - $63,393
825 Added 0.28%
297,973 $21.2 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $299,484 - $329,837
-4,124 Reduced 1.37%
297,148 $22.9 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $95,048 - $113,971
1,546 Added 0.52%
301,272 $22 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $81,034 - $94,467
-1,511 Reduced 0.5%
299,726 $18.7 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $16,449 - $19,268
-278 Reduced 0.09%
301,237 $17.8 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $40,984 - $44,632
-662 Reduced 0.22%
301,515 $20.1 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $57,025 - $64,137
-961 Reduced 0.32%
302,177 $19.1 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $13,106 - $14,852
-227 Reduced 0.07%
303,138 $18.8 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $300,244 - $332,709
-5,228 Reduced 1.69%
303,365 $18.3 Million
Q2 2020

Aug 10, 2020

SELL
$54.82 - $64.09 $1.09 Million - $1.28 Million
-19,923 Reduced 6.06%
308,593 $18.1 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $220,307 - $320,157
-4,748 Reduced 1.42%
328,516 $18.3 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $73,322 - $95,643
1,490 Added 0.45%
333,264 $21.4 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $209,957 - $248,935
-4,909 Reduced 1.46%
331,774 $16.8 Million
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $34.7 Million - $38.3 Million
-776,805 Reduced 69.76%
336,683 $15.3 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $31.8 Million - $38 Million
705,565 Added 172.97%
1,113,488 $53.1 Million
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $35.7 Million - $46.3 Million
-732,565 Reduced 64.23%
407,923 $21.2 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $662,280 - $747,000
-12,000 Reduced 1.04%
1,140,488 $70.8 Million
Q2 2018

Aug 09, 2018

SELL
$50.53 - $62.98 $520,459 - $648,694
-10,300 Reduced 0.89%
1,152,488 $63.8 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $54.3 Million - $62.5 Million
906,415 Added 353.55%
1,162,788 $73.5 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $47,412 - $51,691
791 Added 0.31%
256,373 $16 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $2.02 Million - $2.33 Million
36,632 Added 16.73%
255,582 $16.3 Million
Q2 2017

Aug 15, 2017

BUY
N/A
218,950
218,950 $12.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Argent Capital Management LLC Portfolio

Follow Argent Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.